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Abstract
Background: d-α-tocopherol is a naturally occurring form of vitamin E not previously known to
have antitumor activity. Synthetic vitamin E (sE) is a commonly used dietary supplement consisting
of a mixture of d-α-tocopherol and 7 equimolar stereoisomers. To test for antilipid peroxidation
and for antitumor activity of sE supplementation, two groups of nude mice bearing a MDA-MB 231
human breast cancer tumor were fed an AIN-76 diet, one with and one without an additional 2000
IU/kg dry food (equivalent to 900 mg of all-rac-α-tocopherol or sE). This provided an intake of
about 200 mg/kg body weight per day. The mice were killed at either 2 or 6 weeks after the start
of dietary intervention. During necropsy, tumor and host tissues were excised for histology and
for biochemical analyses.
Results:  Tumor growth was significantly reduced by 6 weeks of sE supplementation.
Thiobarbituric acid reactive substances, an indicator of lipid peroxidation, were suppressed in
tumor and in host tissues in sE supplemented mice. In the sE treated mice, the fatty acid
composition of microsomal and mitochondrial membranes of tumor and host tissues had
proportionately less linoleic acid (n-6 C 18-2), similar levels of arachidonic acid (n-6 C 20-4), but
more docosahexanoic acid (n-3 C 22-6). The sE supplementation had no significant effect on blood
counts or on intestinal histology but gave some evidence of cardiac toxicity as judged by myocyte
vacuoles and by an indicator of oxidative stress (increased ratio of Mn SOD mRNA over GPX1
mRNA).
Conclusions: At least one of the stereoisomers in sE has antitumor activity. Synthetic vitamin E
appears to preferentially stabilize membrane fatty acids with more double bonds in the acyl chain.
Although sE suppressed tumor growth and lipid peroxidation, it may have side-effects in the heart.
Background
Vitamin E is an essential fat-soluble vitamin. The general
term vitamin E refers to eight naturally occurring and syn-
thetic tocopherols and tocotrienols and their acetate and
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succinate derivatives. Although the naturally occurring
forms of vitamin E have lipid-soluble antioxidant proper-
ties that protect cell membranes against damage by free
radicals, the acetate and succinate derivatives that are es-
terified at the C-6 position of the chromanol ring do not
have antioxidant properties unless the esterification is hy-
drolyzed and free tocopherol is regenerated [1–3].
Synthetic vitamin E, a form of vitamin E commonly used
as a dietary supplement, is the form used in the in vivo
studies reported here. It is a mixture of eight stereoisomers
in equal amounts designated "dl" or all-rac tocopherol
and does have antioxidant properties [4]. Thus, different
forms of vitamin E can have different antioxidant proper-
ties as well as differences in their absorption, distribution,
and metabolism [4]. There are also reports that some
forms of vitamin E have activity against cancer cells in vitro
[3,5]. For example, tocotrienol and vitamin E succinate
are reported to have antiproliferative activity in human
cancer cells whereas some forms of vitamin E are reported
to induce apoptosis in cancer cell types but not in normal
cell types [3]. Specifically, these apoptogenic forms in-
clude RRR-α-tocopheryl succinate and RRR-δ-tocopherol
while the α, β, and γ tocopherol and acetate derivatives of
tocopherol were not apoptogenic [3]. There are few re-
ports on the use of vitamin E for treating tumorous can-
cers in vivo but the results are inconsistent [4–10]. It is
therefore essential that the form of vitamin E used in any
research study as well as the dosage and the mode of ad-
ministration be defined.
The study reported on here was originally designed to test
the ability of a high dietary dose of sE to prevent lipid per-
oxidation in nude mice bearing a human breast cancer xe-
nograft MDA-MB-231 [11,12]. To assure suppression of
lipid peroxidation, sE was added to the diet at a dose level.
For example, the vitamin E requirement for mice when
all-rac-α-tocopherol acetate is used as the dietary source is
32 mg/kg for diets in which lipids comprise less than 10
percent of the diet [1]. Thus, the 900 mg/kg diet used in
this study is 28 fold higher than this estimated require-
ment. This is in contrast to human recommendations
which are given in mg of α-tocopherol equivalents with
the adult RDA set at 15 mg/day and the upper limit set at
1000 mg/day. The observed antitumor activity of this sE
dietary supplementation was an unexpected experimental
result as sE was not previously reported to have antitumor
activity although vitamin E may give modest protection
against the risk of breast cancer [5]. Based on the observed
antitumor activity of high dose sE in the diet, it became
important to investigate if the sE supplement, when fed at
such a high dose, was associated with the modification of
the fatty acid composition of mitochondrial and micro-
somal membranes and if the sE was acting as an antioxi-
dant or possibly a prooxidant in tumor and in host
tissues. Given that such a high dose of sE has antitumor
activity, it also became important to look for possible
side-effects in host tissues prior to further preclinical trials.
Results
Tumor growth
The mean tumor growth rate was calculated using linear
regression analysis of mean tumor size over time. After
two weeks of dietary intervention, the mean growth rate
of the group of mice fed the sE supplement was half that
of mice not fed the sE supplement however this difference
was not quite significant at the p < 0.05 level. Tumor
growth rate in mice not sacrificed after 2 weeks of dietary
intervention was followed for an additional four weeks.
Analysis of mean tumor growth rate for the entire 42 days
of intervention revealed that the mean tumor growth rate
of mice fed the sE supplement was 63% slower than the
mean tumor growth rate of mice not fed the sE supple-
ment (significant at p < 0.01 as illustrated in Fig. 1).
Lipid peroxidation
Tumor and host tissue malondialdehyde and malondial-
dehyde by-products were analyzed by the thiobarbituric
acid reactive substrates (TBARS) assay to estimate the ex-
tent of lipid peroxidation after six weeks of intervention.
The TBARS findings are summarized in Fig. 2. The mean
value of TBARS was significantly (p < 0.01) lower in the
tumor and in the liver of the mice fed sE but was not sig-
nificantly different (p > 0.05) in the colon.
Figure 1
Rate of human MDA-MB-231 breast cancer tumor growth in 
nude mice fed the AIN-76 food formula without (-) and with 
(+) synthetic vitamin E supplementation (2000 IU/kg dry 
food) for six weeks (mean ± SE, n = 5 mice/group). Linear 
regression slopes of data indicated. Slopes are significantly (p 
< 0.01) different due to vitamin E supplement.
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Fatty acid composition of microsomal and of mitochondri-
al membranes
Data on the percent of the total fatty acid composition for
linoleic acid (LA), for arachidonic acid (AA), and for do-
cosahexanoic acid (DHA) in the microsomal and in the
mitochondrial fractions of tumor, of liver, and of colon af-
ter two weeks of dietary intervention both with and with-
out sE supplementation are summarized in Table 1. The
mean levels of LA were lower in both microsomal and mi-
tochondrial fractions of the tumor, the liver, and the co-
lon of mice fed sE than in mice without the sE. That 6 of
6 mean values of LA were lower with sE supplementation
indicates a consistent pattern of membrane LA composi-
tion change in the tumor and in the host tissues. Con-
versely, the mean level of DHA was higher in the
microsomal and mitochondrial fractions of the tumor,
the liver, and the colon of mice fed sE than in mice with-
out the sE supplement. That 6 of 6 mean values of DHA
were higher with sE supplementation indicates a consist-
ent pattern of membrane DHA change in the tumor and
in the host tissues. The mean level of AA in the membrane
fractions of the three tissues was not consistently changed.
To further explore the effect of sE supplementation on
membrane fatty acid composition, the relative level of
each of the three fatty acids in each fraction of each tissue
was expressed as a ratio of the level with sE supplement
over the level without sE supplement. The results of this
exercise are plotted in Fig. 3. The ratio is consistently low-
er than unity for LA (mean 0.70) and consistently higher
than unity for DHA (mean 4.9). The mean ratio for AA
was near one, indicating no significant difference.
Body weight
Data on change in body weights at two weeks and at six
weeks from the body weight at the start of dietary inter-
vention are summarized in Table 2. The mean values for
change in body weights at two or at six weeks are not sig-
nificantly different due to diet. The body weight loss ob-
served at six weeks can be attributed to the presence of the
growing tumor.
Blood counts
Results of blood counts, as summarized in Table 3, reveal
no significant differences in white cell (WBC), in red
Figure 2
Effect of six weeks dietary intervention with the AIN-76 food 
formula without (-) or with (+) synthetic vitamin E supple-
ment (2000 IU/kg dry food) on lipid peroxidation as assessed 
by thiobarbituric acid reactive substrates (TBARS). Number 
of mice analyzed ranged from 3 to 5. a Significantly (p < 0.01) 
lower than without vitamin E supplement
Assay results for lipid peroxidation in
tumor and in host tissues
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Figure 3
Mean ratio (% of total fatty acid composition in: + sE supple-
ment/- sE supplement) of linoleic acid (LA), arachidonic acid 
(AA), and docosahexanoic acid (DHA) in microsomal and 
mitochondrial fractions of tumor, liver, and colon after two 
weeks consumption of the vitamin E supplement (analyses of 
all mean values in Table 1). Mean was lower for LA (0.70) and 
was higher for DHA (4.9).
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blood cell (RBC) or in platelet (PLT) numbers due to two
weeks of sE supplementation.
Colon histology
Colon crypt height expressed in number of cells from the
crypt base to the crypt mouth was scored as an indicator
of damage attributable to sE supplementation. The crypt
column heights, (number of cells, mean ± SE) was 21.24
± 0.54 (15) for mice without the sE supplementation and
21.63 ± 0.51 (11) for mice with the sE supplementation.
These means are not significantly different. No histologi-
cal differences attributable to the dietary intervention with
sE were observed.
Heart histopathology and antioxidant enzyme gene 
expression
Histological cross-sections of the heart taken one-third of
the distance from the apex were studied for indications of
side-effects of high dietary levels of sE. Vacuole formation
in the cardiac myocytes has been used as a marker of car-
diotoxicity [13]. The mean percent of cardiac myocytes
with one or more vacuoles in the subendocardial
Table 1: The percent of total fatty acid composition of linoleic acid (LA, n6 18-2), arachidonic acid (AA, n6 20-4), and docosahexaenoic 
acid (DHA, n3 22-6) in microsomal and in mitochondrial fractions of tumor, of liver and of colon following a two week dietary 
intervention of AIN·76 food formula without (-) and with (+) supplementation with synthetic vitamin E (2000 IU/kg dry food). Mean ± 
SD and number of mice (n) are listed.
Vitamin E supplement Fraction n LA, 18-2a AA, 20-4 DHA, 22-6b
Tumor
- Micro 4 8.7 ± 5.0 7.4 ± 12 0.3 ± 0.3
+ " 5 1.9 ± 2.1 7.9 ± 4.2 1.3 ± 1.3
- Mito 4 7.0 ± 5.9 9.6 ± 2.8 0.2 ± 0.5
+ " 5 4.4 ± 5.9 5.8 ± 3.7 2.3 ± 4.9
Liver
- Micro 4 12.9 ± 5.1 4.9 ± 1.8 1.0 ± 0.9
+ " 5 11.3 ± 1.7 5.4 ± 0.9 1.8 ± 0.3
- Mito 4 14.2 ± 1.5 8.0 ± 0.9 0.5 ± 0.1
+ " 5 12.9 ± 1.2 6.1 ± 1.8 1.4 ± 0.5
Colon
- Micro 3 5.3 ± 2.1 6.3 ± 2.2 0.3 ± 0.3
+ " 5 4.6 ± 1.2 4.1 ± 1.3 2.4 ± 1.1
- Mito 3 9.4 ± 2.1 2.9 ± 0.2 0.8 ± 0.5
+ " 5 6.3 ± 1.3 3.7 ± 1.6 1.8 ± 1.0
a6 of 6 means lower with vitamin E supplement (p < 0.01 by Fisher's exact test) b6 of 6 means higher with vitamin E supplement (p < 0.01 by Fisher's 
exact test)
Table 2: Change in body weight (g) at two weeks and at six weeks 
from the start of dietary intervention with AIN·76 formula ± 
supplementation with 2000 IU/kg of dry food with synthetic 
vitamin E (mean ± SE, number of mice in parenthesis).
Vitamin E supplement Two weeks Six weeks
- 0.38 ± 0.30 (15) -0.25 ± 0.53 (8)
+ 0.22 ± 0.22 (17) -0.16 ± 0.29 (5)
No significant difference due to supplement at two or six weeks 
Weight loss at six weeks attributed to growing tumor.
Table 3: Hematological measurements in nude mice bearing 
MDA-MB-231 breast carcinoma xenografts after 
supplementation with (+) or without (-) synthetic Vitamin E (2000 
IU/kg food) (mean ± SE, numbers of mice in parentheses) for two 
weeks.
Vitamin E supplement WBC m/µlR B C  m / µlP L T  k / µl
- (3) 0.62 ± 0.14 8.77 ± 0.04 471 ± 173
+ (4) 1.04 ± 0.43 8.50 ± 0.15 461 ± 130
WBC, RBC, and PLT counts were not significantly different due to 
diet.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/3
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myocytes of the left ventricle was significantly (p < 0.05)
higher in mice fed the sE supplement (Fig. 4). Based on
this indication of cardiotoxicity, the remaining portion of
the heart that had been snap frozen in liquid nitrogen at
the time of sacrifice was used to look for differences in
expression of antioxidant genes using quantitative RT PCR
methodology.
The results of the RT PCR findings are summarized in Ta-
ble 4. Of the antioxidant enzyme mRNAs measured, the
only mRNA that differed significantly due to diet was the
inducible form of heme oxygenase, which is identical to
heat shock protein 32. A complete set of data was taken on
each heart, which allowed calculation of the ratio of each
antioxidant gene transcript to each of the other gene tran-
scripts. The results of this ratio analysis reveal that the
feeding of sE supplement caused the ratio of MnSOD over
GPX-1 to significantly increase (see Table 4).
Assay for chromosomal breakage or loss
The presence of one or more micronuclei in peripheral
erythrocytes in mice is an accepted marker of chromosom-
al breakage or loss that occurred prior to the extrusion of
the nucleus during erythrocyte differentiation. Results of
the scoring of the numbers of peripheral erythrocytes with
and without a micronucleus are summarized in Table 5.
Included in Table 5 are data from mice treated with a se-
ries of injections of doxorubicin. Doxorubicin (DOX) is a
cytotoxic drug with prooxidant properties known to cause
genotoxic damage resulting in an increase in number of
erythrocytes with a micronucleus. The results from the
DOX treated mice served as a positive control. Results of
statistical analyses demonstrate a significant increase in
erythrocytes with micronuclei due to DOX treatment but
no significant difference due to sE supplementation. Note
that the highest mean incidence of micronuclei occurred
in the group of mice fed the sE supplement and treated
with DOX.
Discussion
Vitamin E was established as an essential micronutrient
for proper fetal development [1] and the amount of vita-
min E required to maintain proper fetal development has
been defined in International Units. In addition to its role
in reproduction, vitamin E is known to be a lipid-soluble
antioxidant that blocks peroxidation of polyunsaturated
fatty acids in cellular membranes and is known to stabi-
lize biological membranes [14–17]. Because vitamin E
has multiple biological activities, it is best to report dosage
in weight units. The recommended dietary allowance and
tolerable upper intake limit for sE, the commercially
available form, has been calculated to be about 22 and
1470 mg per day respectively for 70 kg adult humans [1].
In animal species, oral intake of up to 200 mg/kg body
weight per day was reported not to result in noticeable
side effects [18]. Thus, we selected to use a dietary dose of
sE at the level of 200 mg/kg body weight per day in tumor
bearing mice in an attempt to maximize inhibition of lip-
id peroxidation in the cellular membranes of the tumor
without an expectation of finding harmful side-effects.
Specifically, this experiment was originally designed to
test the hypothesis that DOX, a prooxidative cancer chem-
otherapeutic drug, inhibits tumor growth by increasing li-
pid peroxidation products in the tumor to cytostatic or
cytotoxic levels and that suppression of lipid peroxidation
by sE would suppress the antitumor effects of DOX
[11,12]. The results demonstrated that sE supplementa-
tion did markedly suppress DOX-induced lipid peroxida-
Figure 4
The percent of cardiac myocytes with vacuoles in the suben-
docardial myocytes of the left ventricle scored in 4 µm thick 
hematoxylin and eosin stained sections. At least 500 myo-
cytes were scored per heart. The means (± SE) of 4 (-) and 7 
(+) hearts are graphed.
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tion, yet tumor growth was still suppressed in mice treated
with DOX and sE. It was concluded that increased levels
of lipid peroxidation products were not the sole cause of
tumor growth inhibition by DOX. As reported here (Fig.
1), the dietary supplementation with this high dose of sE,
by itself, retarded tumor growth to a significant extent.
It is not known how such a high intake of sE works to sup-
press tumor growth. What is known from the current
study is that the sE supplement reduced lipid peroxidation
(Fig. 1) and preferentially stabilized membrane polyun-
saturated fatty acids with more double bonds (Fig. 3). It
has been proposed that vitamin E may incorporate into
cellular membranes by association of the tocopherol side
chain with the polyenoic fatty acid residues in the mem-
brane fatty acids [15,19]. This interaction may stabilize
cell membranes by making highly unsaturated fatty acids
less liable to peroxidation as well as by making highly un-
saturated fatty acids less available for phospholipid hy-
drolysis by phospholipase [15,16]. The latter action may
reduce mobilization of arachidonic acid (AA) from the
membranes and in this way reduce the amount of AA
available as a substrate to cyclooxygenase and/or
lipoxygenase to produce eicosanoids with mitogenic and
with inflammatory properties [17,20]. Other possible an-
titumor actions include: induction of apoptosis, interfer-
ence with hormone production, modulation of cellular
signaling and gene transcription, and induction of differ-
entiation [4,21–24].
In comparison to the inhibitory effect of vitamin E on
mammary tumor growth (this report), Cognault et al. re-
port a stimulatory effect of vitamin E on mammary tumor
growth. Specifically, Cognault et al. report that when the
diet was high in omega-3 PUFAs, tumor growth was sig-
nificantly increased by vitamin E supplementation. How-
ever, when the diet was relatively low in omega-3 PUFAs,
the promotional effect of vitamin E was not observed [8].
It is noteworthy that the diet used in the presently report-
ed study was very low in omega-3 PUFAs and that this di-
et, combined with the high dietary level of sE, resulted in
suppression of tumor growth. Thus, the different results
may be attributable to the type and the amount of omega-
3 polyunsaturated fatty acids (PUFAs) in the diet.
Evidence for cardiotoxicity, as observed in this study, was
not expected as supplementation with vitamin E at ex-
tremely high doses gave no significant indications of
harmful side-effects in animals or in humans [18,25]. Per-
haps vitamin E supplementation acts to inhibit lipid per-
oxidation but at the same time acts to down regulate other
protective antioxidant systems as suggested by the antioxi-
dant enzyme gene expression data in Table 4. If gene ex-
pression levels in Table 4 reflect antioxidant enzyme
activity, then an increase in SOD and decrease in GPX
without an increase in CAT would result in accumulation
of inorganic and organic peroxides and hydroperoxides
that can react with Fe2+ to yield highly reactive free radical
products that can damage cellular proteins and DNA as
well as lipids. Likewise, the sE supplementation used
caused low expression of the stress-induced isoform of
heme oxygenase, (HO-1). HO-1 catalyzes the breakdown
of prooxidant heme to biliverdin with release of carbon
monoxide and iron ion. It should be realized that these
observations are suggestive of cardiotoxicity but are not
definitive.
Early studies suggested that vitamin E lessened the cardio-
toxic effects of DOX chemotherapy [26] whereas other
studies indicate potentiation of DOX induced cardiotoxic-
ity [27,28]. Shinoyawa et al. [28] suggest that vitamin E,
when combined with DOX, may increase levels of toxic
products in the heart and in the tumor while Liu and Tan
[27] suggest that vitamin E may have prooxidant proper-
ties at high dosage levels.
The micronuclei results in Table 5 suggest that while sE
protects against lipid peroxidation, it did not protect the
genome of erythroblasts against the prooxidant effects of
DOX in this study. Thus, while the toxic effect of DOX was
Table 4: Results of quantitative RT-PCR for antioxidant enzyme gene expression in the heart of mice fed the AIN·76 food formula with 
(+) or without (-) a synthetic vitamin E supplement (2000 IU/kg dry food) for six weeks. 
Enzymea
Vitamin E supplement GPX-1 CAT CZ SOD Mn SOD EC SOD HO-1b Mn SODb GPX-1
- .325 ± .019 .495 ± .048 .915 ± .038 2.106 ± .166 .064 ± .005 .020 ± .002 6.55 ± 0.56
+ .252 ± .028 .522 ± .029 .915 ± .054 2.538 ± .175 .059 ± .005 .013 ± .002 10.49 ± 1.16
a Abbreviations: GPX-1 – glutathione peroxidase; CZ SOD – copper zinc superoxide dismutase; CAT – catalase; Mn SOD – manganese superoxide 
dismutase; EC SOD – extracellular superoxide dismutase; HO-1-inducible form of heme oxygenase b Means differ to significant extent using two-
tailed t test. Data are presented as the mean ± SE number of transcripts for each mRNA after normalization to expression of beta actin. N = 5 mice 
per group.Cancer Cell International 2003, 3 http://www.cancerci.com/content/3/1/3
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not significantly enhanced by vitamin E supplementation,
neither was the toxic effect of DOX lessened by vitamin E
supplementation.
Conclusion
The adage that more is better may not hold true for vita-
min E as there may be beneficial effects at certain levels
but not at high levels. Clearly, more research is needed on
the antitumor effects of sE but caution is advised that sE
may also have side-effects in the heart.
Methods and Materials
Methods involving: preparation of cells, animals, tumor
and body weight measurements, necropsy and tissue
processing, products of lipid peroxidation, gas chroma-
tography, and statistical analyses have been described in a
prior issue of this journal [12]. The source of dl-α-toco-
pherol (synthetic vitamin E) was ICN Biochemical (Costa
Mesa, CA). This experiment was conducted at the Univer-
sity of Texas Health Science Center at San Antonio. All
animal use and handling was approved by UTHSCSA In-
stitutional Animal Care and Use Committee.
Diet components, chemicals and composition
Purified high nitrogen casein, pure cornstarch, Alphacel
(non-nutritive bulk cellulose), AIN-76 vitamin mixture,
AIN-76 mineral mixture and choline bitartrate (99%
pure) were obtained from ICN Nutritional Biochemicals,
Cleveland, OH. Imperial brand (Sugarland, TX) extra fine
pure cane sugar and 100% pure corn oil (Wesson) were
purchased locally. D.L. methionine was purchased from
Sigma, St. Louis, MO. Corn oil contains about 50% lino-
leic acid, 23% oleic acid, 10% C16 fatty acids and <1% n-
3 PUFAs. The composition of the diet was as follows: 5%
corn oil, 50% sugar, 20% casein, 15% cornstarch, 1%
AIN-76 vitamin mix (the mix contains 20 g/kg of dl-α-to-
copherol acetate), 3.5% AIN-76 mineral mix, 0.2%
choline bitartrate, 0.3% D.L. methionine, and 5% Alpha-
cel fiber [12].
Histological analyses of heart and colon
At sacrifice, the heart and colon were removed. The heart
was crosscut through the ventricles 1/3 of the distance be-
tween the apex and the atrium, and then the apex section
was fixed in OmniFix II (Mt. Vernon, NY) and then em-
bedded, cut surface down, in molten paraffin. This
provided a consistent histological section for estimates of
myocyte vacuolization and toxicity. Four µm thick sec-
tions were stained with hematoxylin and eosin. The
number of myocytes with vacuoles in the subendocardial
region of the left ventricle was counted. Cross sections of
the descending colon were scores for number of cells in a
crypt column from crypt base to mouth.
Blood counts
Blood was obtained by cardiac puncture at sacrifice and
assayed within 3 hours of collection. A Coulter STKS he-
matology analyzer was used for counts of red blood cells,
white blood cells, and platelets in EDTA anticoagulated
blood of the mice.
Micronucleus assay
At the time of necropsy, blood was collected by heart
puncture using a 1 ml syringe fitted with a 22G needle.
Immediately, small drops of blood were placed on clean
microscopic slides. The blood was pushed behind another
slide held at a 45° angle to form a thin smear over an area
of 3–4 cm. All smears were air-dried for 30–45 minutes.
The cells on the slides were fixed in absolute methanol for
30 minutes. All slides were air-dried and stored in a box
kept in a dark place at room temperature or at 4°C. The
slides were stained with acridine orange before micro-
scopic evaluation.
All slides were examined under 1000× magnification us-
ing a fluorescent microscope fitted with appropriate filters
for acridine orange stain. For each animal, the percentage
of 1000 erythrocytes with micronuclei was scored.
RNA extraction and quantitative reverse transcription-
polymerase chain reaction
All heart samples were immediately frozen in liquid nitro-
gen for RNA extraction. RNA was extracted by standard
methods [29] and analyzed by reverse transcription fol-
lowed by real-time quantitative polymerase chain reac-
tion (PCR) for the transcripts of interest. The
methodology of quantitative PCR has been described in
detail previously [30]. Specific quantitative assays were
designed from mouse sequences available in GenBank™.
Primers and probes were designed from nonconserved se-
quences of the genes (allowing for isoform specificity),
Table 5: Results of peripheral erythrocyte (RBC) assay for 
chromosomal breakage or loss. Frequency of micronuclei (MN) 
per 2000 erythrocytes counted in blood smear from each mouse 
(mean ± SE, n = number of mice).
Vitamin E supplementa ± DOXb n MN/2000 RBCsC
- - 5 7.6 ± 1.4d
- + 6 15.5 ± 2.5e
+ - 5 5.6 ± 1.1d
+ + 8 19.3 ± 1.9e
aAdded (+) synthetic vitamin E at 2000 IU/kg dry AIN·76 food bDOX 
= doxorubicin treatment: 5 mg/kg body weight i.v. in a lateral tail vein 
starting two weeks after start of dietary modification and given at 0, 4, 
8, 12, 19, 26 and 33 days. Blood smears were made and stained with 
acridine orange one day after the last injection of DOX. cResults of 2-
way ANOVA, significant main effect due to DOX. Results of SNK 
multiple comparison test, means in column which do not share a 
superscript letter are significantly different, p < 0.05Publish with BioMed Central    and   every 
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spanning sites where two exons join (splice sites) when
such sites are known (preventing recognition of the assay
to any potential contaminating genomic DNA). Standard
RNA was made for all assays by the T7 polymerase meth-
od (Ambion, Austin, TX), using total RNA isolated from
the mouse heart. The correlation between the Ct  (the
number of polymerase chain reaction cycles required for
the fluorescent signal to reach a detection threshold) and
the amount of standard was linear over at least a 5-log
range of RNA for all assays (data not shown). The level of
transcripts for the constitutive gene product β-actin was
quantitatively measured in each sample to control for
sample-to-sample differences in RNA concentration.
Polymerase chain reaction data are reported as the
number of transcripts/number of β-actin molecules.
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